Agile Therapeutics, Inc. Profile Avatar - Palmy Investing

Agile Therapeutics, Inc.

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combinatio…

Drug Manufacturers - Specialty & Generic
US, Princeton [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of AGRX's Analysis
CIK: 1261249 CUSIP: 00847L100 ISIN: US00847L3087 LEI: - UEI: -
Secondary Listings
AGRX has no secondary listings inside our databases.